페니트리움바이오 사업보고서 (2023.12)
1. 요약재무정보

1) 요약연결재무정보(단위: 원)

구분	제22기 당기말(2023년 12월말)	제21기 전기말(2022년 12월말)	제20기 전전기말(2021년 12월말)

[유동자산]	25,555,266,153	40,589,451,279	35,449,587,354

ㆍ현금및현금성자산	3,372,575,210	3,097,124,698	5,270,184,762

ㆍ단기금융상품	15,601,000,000	24,000,000,000	25,500,000,000

ㆍ당기손익-공정가치측정금융자산	-	7,972,804,866	-

ㆍ매출채권및기타채권	4,829,834,701	3,985,136,066	3,905,403,355

ㆍ재고자산	1,162,854,413	402,481,233	203,511,556

ㆍ기타유동자산	589,001,829	1,131,904,416	570,487,681

[비유동자산]	18,658,927,574	5,702,953,933	2,915,136,984

ㆍ관계기업투자주식	871,971,044	952,060,316	866,392,841

ㆍ당기손익-공정가치측정비유동금융자산	974,520,000	224,364,912	-

ㆍ유형자산	2,849,220,036	2,792,157,646	1,422,277,479

ㆍ무형자산	1,081,519,184	973,401,615	82,503,859

ㆍ투자부동산	11,720,483,348	-	-

ㆍ기타비유동자산	1,161,213,962	760,969,444	543,962,805

자산총계	44,214,193,727	46,292,405,212	38,364,724,338

[유동부채]	15,296,655,852	14,207,021,960	4,490,963,031

[비유동부채]	1,789,955,526	1,375,585,374	417,182,320

부채 총계	17,086,611,378	15,582,607,334	4,908,145,351

지배기업소유주지분	27,150,789,792	30,340,609,792	33,587,113,905

[자본금]	2,183,625,000	2,183,625,000	2,183,625,000

[자본잉여금]	20,418,648,438	20,418,648,438	21,176,961,109

[기타자본]	(3,727,813,651)	(3,723,279,478)	(958,128,802)

[이익잉여금]	8,276,330,005	11,461,615,832	11,184,656,598

비지배지분	(23,207,443)	369,188,086	(130,534,918)

자본 총계	27,127,582,349	30,709,797,878	33,456,578,987

관계기업 투자주식의 평가방법	지분법	지분법	지분법

2023.1.1~2023.12.31	2022.1.1~2022.12.31	2021.1.1~2021.12.31

매출액	13,790,195,699	14,882,555,787	13,977,771,687

영업이익	(3,464,613,885)	(754,740,449)	2,090,550,559

당기순이익	(3,363,294,388)	(58,882,743)	1,726,994,313

지배기업소유주지분	(2,970,313,225)	266,502,935	1,922,576,382

비지배지분	(392,981,163)	(325,385,678)	(195,582,069)

주당순이익	(140)	12	96

희석주당이익	(87)	3	-

2) 요약재무정보(단위: 원)

구분	제22기 당기말(2023년 12월말)	제21기 전기말(2022년 12월말)	제20기 전전기말(2021년 12월말)

[유동자산]	26,416,763,716	39,845,619,438	35,205,056,876

ㆍ현금및현금성자산	3,326,420,831	3,084,101,544	5,248,576,920

ㆍ단기금융상품	15,601,000,000	24,000,000,000	25,500,000,000

ㆍ당기손익-공정가치측정금융자산	-	7,972,804,866	-

ㆍ매출채권및기타채권	6,775,291,022	3,726,662,122	3,931,345,399

ㆍ기타유동자산	714,051,863	1,062,050,906	525,134,557

[비유동자산]	18,179,783,943	7,078,266,068	3,387,635,609

ㆍ당기손익-공정가치측정비유동금융자산	974,520,000	224,364,912	-

ㆍ종속기업투자주식	1,907,636,272	3,815,272,544	745,514,300

ㆍ관계기업투자주식	743,773,620	743,773,620	743,773,620

ㆍ유형자산	1,368,990,257	1,461,088,871	1,343,584,217

ㆍ무형자산	266,663,505	64,383,068	10,800,667

ㆍ투자부동산	11,720,483,348	-	-

ㆍ기타비유동자산	1,197,716,941	769,383,053	543,962,805

자산총계	44,596,547,659	46,923,885,506	38,592,692,485

[유동부채]	15,144,738,418	13,934,446,459	3,827,556,345

[비유동부채]	661,875,854	182,535,087	384,959,664

부채 총계	15,806,614,272	14,116,981,546	4,212,516,009

[자본금]	2,183,625,000	2,183,625,000	2,183,625,000

[자본잉여금]	21,395,991,395	21,395,991,395	21,395,991,395

[기타자본]	(3,739,155,755)	(3,739,155,755)	(1,002,112,265)

[이익잉여금]	8,949,472,747	12,966,443,320	11,802,672,346

자본 총계	28,789,933,387	32,806,903,960	34,380,176,476

종속,관계투자주식의 평가방법	원가법	원가법	원가법

2023.1.1~2023.12.31	2022.1.1~2022.12.31	2021.1.1~2021.12.31

매출액	13,790,195,699	14,881,305,787	13,972,489,868

영업이익	(1,911,004,834)	516,521,349	2,412,505,411

당기순이익	(3,800,188,519)	1,144,040,937	2,139,448,681

주당순이익	(180)	53	107

희석주당이익	(124)	42	-